Escherichia coli (E. coli) is one of the most well-known and at the same time insidious microorganisms facing medicine. This bacterial "inhabitant" of our body usually peacefully coexists with humans, but under certain conditions it can transform into a dangerous pathogen. Add antibiotic resistance to this, and we have a real threat that traditional medications can no longer combat.
This is where bacteriophages—our microscopic allies in the war against bacteria—come into play. These viruses are increasingly attracting the attention of scientists and clinicians as an alternative to antibiotics. In this article, we'll explore the dangers of E. coli, how it spreads, the diseases it causes, and how phage therapy is opening up new horizons in its eradication.
E. coli is a gram-negative rod-shaped bacterium that normally lives in the human intestine and participates in digestion, produces B vitamins, and helps maintain microflora balance. However, this only applies to harmless strains.
Problems arise when pathogenic strains of E. coli enter the body , which can cause:
acute gastroenteritis;
urinary tract infections;
meningitis in newborns;
sepsis;
pneumonia in immunocompromised patients.
Infection most often occurs through consumption of raw or undercooked meat, contaminated water, dairy products, or vegetables processed with contaminated water. Infection is also possible through contact with other people, especially in kindergartens, hospitals, and summer camps.
To prevent infection, you should follow simple rules: wash your hands, cook food thoroughly, avoid drinking unboiled water, and handle vegetables and fruits.
In recent decades, the widespread and often uncontrolled use of antibiotics has led to the emergence of strains of E. coli that are largely unresponsive to treatment. Specifically:
ESBL-producers ( Extended Spectrum Beta-Lactamases): produce enzymes that destroy penicillins and cephalosporins.
MDR (multi-drug resistant): resistant to three or more classes of antibiotics.
This means that conventional medications are no longer able to stop the infection. Such cases most often occur in hospitals, among patients with catheters, after surgery, or in people with weakened immune systems.
The clinical picture becomes more severe: most illnesses that typically resolve within 5–7 days linger for weeks. The risk of complications, recurrent infections, and even death increases.
Bacteriophages are naturally occurring viruses that infect and destroy exclusively bacteria. They penetrate the microorganism's cell, replicate within it, and then rupture it from the inside.
Unlike antibiotics, which have a broad spectrum of action and destroy both harmful and beneficial intestinal microflora, phage therapy has a targeted, selective mechanism. This makes it particularly valuable for infections caused by E. coli, especially in children, weakened patients, the elderly, and for recurrent infections when antibiotics are no longer effective.
Phage preparations against E. coli can be used in several forms depending on the location of the infection:
Orally - taken in liquid or capsule form, which allows them to reach the intestines and destroy pathogenic bacteria without harming beneficial flora.
Rectally - in the form of microclysters or suppositories to deliver bacteriophages directly to the large intestine, where E. coli is often localized .
Instillation therapy – for urinary tract infections. Phage solutions are injected into the bladder or urethra for direct contact with bacteria.
Locally, ointments, gels or dressings impregnated with phages are used.
In combination with probiotics - in complex therapy to restore microbiota after infection.
High specificity - phages act only on a specific strain of bacteria, without destroying other beneficial microorganisms.
Effective against resistant strains - even those E. coli that do not respond to any existing antibiotics can be destroyed by properly selected bacteriophages.
No side effects - phages do not create a toxic load on the liver or kidneys, do not cause allergies, and do not suppress the immune system.
Recovery after antibiotic therapy - these viruses can be used both for treatment and for the prevention of relapses, especially in patients with chronic forms of the disease.
Possibility of combined use – phage therapy can be effectively combined with antibiotics or other treatment methods, enhancing the overall result.
This approach allows doctors to create individualized treatment protocols, especially in situations where every minute counts and traditional methods no longer work.
Recent studies confirm the effectiveness of phage therapy in treating E. coli infections . Here are some examples from Ukrainian and international experience:
After a kidney transplant, a woman developed a multidrug-resistant Escherichia coli infection . A two-week course of intravenous phage therapy completely eradicated the pathogen. https://bacteriophages.info/ua/news/fagoterapiya-infektsii-escherichia-coli-pislya-transplantatsii-nirok/
A cocktail of bacteriophages successfully combated a strain of E. coli pathogenic to humans without damaging the microbiota in mouse studies.
https://bacteriophages.info/ua/news/fagoviy-kokteyl-viyaviv-efektivnist-proti-ecoli-ta-bezpeku-dlya-kishkovogo-mikrobioma/
Locus Biosciences has received $24 million from the Biomedical Advanced Research and Development Authority to continue developing CRISPR-enhanced bacteriophage therapy to treat urinary tract infections caused by antibiotic-resistant Escherichia coli.
https://bacteriophages.info/ua/news/amerikanska-kompaniya-otrimala-24-mln-dolariv-dlya-rozrobki-fagoterapii-posilenoi-tehnologieu-crispr/
A 2024 study ( PNAS, USA): a new approach to phage selection using machine learning demonstrated high efficacy in treating urinary tract infections. This enabled the creation of rapidly adaptive phage cocktails.
https://www.pnas.org/doi/full/10.1073/pnas.2313574121
E. coli is a bacterium with two faces: a beneficial neighbor under normal conditions and a dangerous enemy during infection, especially when it comes to resistant strains that don't respond to traditional treatments.
Bacteria hunters are giving us a new tool—precise, safe, and promising. Thanks to scientific advances and growing trust in the medical community, phage therapy is no longer an "experiment" but is becoming part of evidence-based medicine.
The best is yet to come. And it's entirely possible that soon the word "antibiotic" will increasingly be replaced by "bacteriophage" in Ukrainian doctors' prescriptions. This will truly become a highly effective weapon against diseases caused by E. coli.